Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
rarediseaseadvisor1mon
Plasmapheresis: A Promising Approach for Managing Severe Rh Incompatibility
Although plasmapheresis showed promise as a treatment to mitigate the risks for severe HDFN, the current study underscored the importance of close monitoring due to potential complications such as ...